OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator. This document is also available as Markdown.

2024-09-30-accounts

Charlty registration number 1091 82 (England and Wales) Company. regis tian number 041111627, THE MOUNTVERNON MARIE CURIE RESEARCH NG TRUST ANNUAL REPORT AND FINANCIAL STATEM NTS FOR THE YEAR ENDED 30 SEPTEMBER 2 24 "• xeinadin

THE MOUNT VERNON MARIE CURIE RESEARCH WING RUST LEGAL AND ADMINISTRATIVE INFO.RMATION Trustees Dr RAlon Prof P HDStvri DrA Makrfs DrKJYChtu Charity number (England and Wales) 1091882 Company number 041.10627 Registered office The Mount Vemon Marie Curie Research 1st Floor, Mount V8mon.Hospital RickmanswDrth Road Northwood Middlesex England HA6 2RN ng Audltor Xeinadin Audit Limited 26 High Street Rlckmansworth Hertfordshire WD3 1ER Rowan Dartlngton & Co. Ltd 1 Emperor Way Exeter Business Park Investment advisors EX13QS

THE MOUNTVERNON MARIE CURIE RESEARCH WING RUST CONTENTS Trustees report Indep8Ddent auditoV8 report Slatement of fjngndal activities Balan￿ sheet Notes to Ihe flnancA] statements 9-16

THE MOUNT VERNON MARIE CURIE RESEARCH WING RUST TRUSTEES: REPORT (INCLUDING DIRECTORS. REPO.RTI FOR THE YEAR ENDED 30 SEPTEMBER 2024 The tnjstèes present thew annual report and fmanaal statementA for the year ended 30 S ptember 2024. The flnan¢ial slaiements have been prepared in acts3rdai￿ wtth the acrx)unting polici finandal statements and Comply with the trusvs governing documenL the Companies Financial Reporting Standard apPr￿abl&. in the UK and RepJblic al treland" and the C and Reportlng by Charitles: Statement of Recommended Practtce apptTcabl8 to ¢harltie> accordance with the Financial Reporting Standard appl(xb18 In the UK and Republic of Ir s set out in notè 1 to the ct 2006. FRS 102 'The rities SORP "Accounting. reparlng thair accounts in tand [FRS 102)°. Obj¢¢tivgs and actlvitles ThE objectives of the Trust are to protect and promote the health of the public in pardtyjla 'the invesllgatton of the causes of (ancer and the prevention, treatm'ent. Gure ari forms., . the 2dvancÉrnent of scientifio and medical education and research into 1￿cOlO c2ncor, and th8'fLn1hèrancg ofany other charitable PUfPOS8 (or the rellef of persons suffering by. defeat of cancer In all Its and all toplcs relating to rom Can￿r. Publlc benefft The. truste8s have pald due regard to guidance fssued by the Charlty Commission in trust should undertake: ciding what activities the.. Ac'hievements and perftymanc'e significant activit16s and achievements agalnst objeobves The Mount Vemon Marlp CurIe Research Wing Trust charty 5tts wjthln the NHS frarne app.lied r8search Into varlous. forms of cancer on bebalf of.a number of organK8ations private. This can indud8 trials of new drugs or treatments which will provide material carter sofferers. rK condudtng both p.ubfic and benefjt to rnany In May 2024 the charffy supported members of 4he Head &. Neck onwlogy t&wn to Associ2tton of Head & Neck Oncology meeting, topic for 2024 was "data outcomes cancer.. For ESTRO 2024 Dr AbdukLatif pr8seriied "Sa￿age brathyther8py in second tumour event. Relating doslrnety with late toxithf, whitst Drs Chowdhurfs, sl￿ and G accepted for The UK Interdisoplinary Breast Cancer Symposium held in January 20 dlsturbanc% amongst tha breast cancer populatEon: a single4errtre prDspectJva exparlen ttend .the British n Head & Neck lateral breast py.'s poster Was . rrtted .. Sleep The trials we.participate.In are fisted as follows: Clinical trfa]s in breast ￿nCer evaluating new drugs in collaboR'tion pharma Clinical trials in prostate and bladdor eancer evaluating nEw drugs h collabo industy partners nlcal frials in prostate ￿nCer evaluatin9 new radiotherapy sdiedules cl1n1￿1 trials In prostst& ￿nCer evaluating new brachytherapy sGhedules Clinical.'Irials in prostatg cancer evatuating salvage brachytherapy crinical trfals in bladder cancer evaluatyng new radiotherapy schedule5 and drug Clinical Irlals ln head and neck Cancer evaluating new radiotherapy schedules an Cllnical trials in'.head and ned( can￿r evaluatiTrJ new drugs in Gollaboration partners uticaE industy partne ttQD th p.ham10c9tsti￿f mbinabor drug comblnatlons pharmacautical industy The Fighting Breast Cancer Campalgn led by Dr Makris and Dr. Miles eoDOnues 10 4Jnd from d¢diGated individuals keen to support the (xmpaign. ke sucLessftEI fundraistng The charity contlnues to receive support.from donations through fundraiseTS uslng J Foundatk)n amongst Others, and wll regularty reviw'any opporiuniknes. for grant appli Suppoitfrom Etsevier.'The ¢harityalso benefits from occasional ffiJnd-￿lS1n9 campaigns Èving and Charitles Afd ons, as well as.on*oing m supp.orters. There: is a continual ftcw o.f publications from Ihe WO.￿ supported by the tharity. In 2 review publications and 8bstra.cls arising from this work. 3124 knere were 65 pear

THE MOUNT VERNON MARIE CURIE RESEARCH WING RUST TRUSTEES. REPORT {INCLUDING DIRECTORS. REPORT) (CONTI FOR THE YEAR ENDED 30 SEPTEMBER 2024 UED) The work of1he charfty is also'presenfed in lecknres both nationally and intemationally Nattonal leclures at the Royal College of Radiologlsts in"London. the Briti Society, British Instilute of Radiology and the British Association of Head & N LectU￿S al thè universltses Oxfor4 cambti.dge and Manchester Lectures at intemaional meetings in Europè, US4 ALtstraEasia: Sri Lanka., and In ding. Gynaeco]ogiEal Cancer n'wlogists (BAHNO) ia During the yearwe accepted the following clinitral Visitors to observe Brachytherap'y proc of Professor Hoskin," Dr Wtwatchai Siknong Trom Siriraj Hospitsl Thailand, for a period of fromAustratla. dures under the guidance 1 year'olso DrA£￿n Kent The Mount Vemon Marie Curia Researclj Wing K% Q)ntinuing to support MD'S for Dr Am Brooks by gponsoring tuition fees for the duration of their eoutse at Manchester Univers .Chowdhury and Dr Chloe Financial revlew The operat50nal.loss of £41518 (2023: 4636 gain). b8for8 the net gain of £126.14 investrnenls. is regarded as sattsfactory In.Mew of the nalure of alt fields of the Trusvs ecc>riomj¢.sStuation. {2023: £34,175 gairij on peratlons and the ￿rrent The nature of,research Is cyclical and the policy of the Trust is notto commit to employi is cèrtainty of fijnding for the- project. Duo to.the speCIa￿Sed naiur6 of the Trusys ectivitl to undèrtake research.can take some tlme. research staff untll'there . f]ndlng.4he right pe￿.0￿8 This is emphasIsed by th8 net assets of £1,6S2,651 (2023: £1,569.022). whiBh i8.suffi forecast commitinents. 8nt to cover Eurrent and Re48￿e$ poHcy It IG 'the policy of the trust 'that unrestriGted funds whith have not been designafed fo malntained at 8 level equlvalent to at least iwelve monlh's expenditure. The I￿stee$ o) level wdl ensure that, in the event of a significant dtop In fundlng. they wll .bg able to activ(tE8s while consideration is given to ways in which adrfrtlonal funds may be raised. been maintained throughout the year. a speofi¢ use should be slder that reseN¢s.at th1$ ntinue the trusl's current is lavel of reseNes has Structure, governance and management The trust i& a company fimited by'guaranl88 Cuitrolled by its goveming document and a d of trust. The trustccs". who are.8lso.the directors for the purpose.of company law. and who ser4e 'thé date of sIgnaiu￿ of Ihe flnancial statements were: Dr R AJor(zi Prof P Hoskin Dr.A Makris DrKJYChi during the ypar and up'to Recniitment and appointment of frustees The Irustees keep themselv.es infom￿￿ of current issues and "rf necessary extra. Irainln needed. is.arranged as and vihen None of the trustees has any beneficlal interest in the o)mpany. All of the.trustses are me guaranteé to ¢ontrfbute £1 in the event of a wtndlng up. bers of the company and

THE MOUNTVERNON MARIE CURIE RESEARCH WING RUST TRUSTEES. REPORT (INCLUDING DIRECTORS. REPO.RT) (CONTI FOR THE YEAR ENDED 30 SEPTEMBER 2024 UED) The company's current:poficy concemlng the payment of ITade (Xedito￿.1S to followthe (copies.are available from the CBI..Centre Polnt, 103 New Oknrd Stre8( London WC14 The. compan￿$ current policy ¢oncemingthe payment of trade cre￿rtOrS Is to: . settle the tenns of payTnent wth sup￿lerS when a9reeing the terms of eath transacti ensur8 that suppliers are made aware. of the tern￿.0f payment by inclusion of thè r and pay in accordance with the comi)anYs cotthctual and olher legal obligations. Bl's Prompt Payers Code DU). levant terrns in contracts;, statement of trustees, responsibilities The trustèes. who are also the dlrector5 of The Mount Vemcjn Marie Curie ReseaTch Wi Company law, are r8sponslbla for preparfng the TrusÉe8s' Report and the finandal stat applicable law ar￿ United Klngdom Accounting Standards (Untted lfjngdom Gene practs"￿). g Trust for Ihe purpose of ments in accordance with. y Ac￿pted AGGounling Company law reqUI￿S the bwtees to prepare financial stafements for 8ath finanGal'yea view of the state of affairs of Ihe trust and of the Incoming resources and application IAcom8.and expenditure, of the charifable cofftpany for thatyaar. which gwe a true and fair f rEsources. .including the In preparing Ihese financial'statements, the tnjslees.are required to". - select suttable accounting pollctes and then apply them consistently, - obseN8 the methods and principles in the Charities SORP", make judgements and estimates thatare reas'onable and prudent and - prepare the financial ststements ori'the going ¢oncem basis unless it is inapproprfate ¢ontinue in operat50n. pr8surn8 that the trust wili The. trusi&ps arp respcnslble for keeping adequate accountlng record5.lhat disolose wi any'time Ihe financial positlon of th8 trust and enable them to ensure that Ihe financial Companles Act 2006. They are also responsible for saleguarding the assets of the. t reasonable steps for11se preventlon and detectton of fra(Kl arKI other trregulariues.. h reasonable accuracy at terrients comply the st and h6nc8 for. laking Audltor In accordance Wilh the C4)mpsnys arlicles. a resolution proposing that Xéinadln Audll auditor of the company will be put at a Genarat Meeting. Imlted be reappointed 2$. Dlsclosure of Infonnatlon to audltor Each of the trusteès has ¢orifirmed that.ther8 Is no information of whlch th&y ara ow• audit. but of which the auditor is unawar8. Thw have further confirmed that thty have identify such relevant information and to establish tr￿t the audilor ts awarg of such infom whith is ve￿vant.10"the ken appropriata staps to The trustees, reportwqs approved. by the. Board of Trust￿ and signed on behalf by. DrR Alonzi Trustee of P Hoskin Date: ...

THE MOUNTVERNON MARIE CURIE RESEARCH WING RUST INDEPENDENT AUDITOR'S REPORT TO THE MEMBERS OF THE MOUNT VERNON MARIE CURIE RES TRUST CH WING Oplnlon We have. audited the financial statèmonts of The Mountvemon Marie Curie Rese*b Wi year ended 30 September 2024 which comprise the statement of financiat activitsès..the the financial ststements, including significant accounting poficies. Th& fin￿tIal reportin appllecf in Iheir preparation is applicable law and United ￿ngdoM Accounting Stan Rèporung Standard 102 The Rnanoal Repo￿ng StarKlarf applicabl8 In the UK and Kingdom GenerallyAccepted Accounting PraCtI￿)- g Trust {the 'trustJ for the lanGe sheet and. notes to, framwork that has been ards, Including Fihancial public of Iralan.d (Unlted In our opinion. the fihanaal ststeTnents: .glve a..(rt￿ and fdir vlew of'the stste of the charitable companvs affalrs as at 30 ihcoming. resour￿ and application of 'resoUr￿s. including ts incomc" and 'exp ended: have- been properly prepared In accordance wlth United Klngdorn Generalty Acc eptember 2024 and of its diture. for the year then ted Atsounllng Practtce; ha!&be8n preparéd in at£thance with the rAquirÈmonts. of th8 Companies Act.20 Basis for opinion We conducted our sU￿rt in accordance Intemational Stsndards (x). Auditing 'lUK) ( law. Our responsibilities under those standards Ére further described In the Auditorfs res the ffnaDual Séat￿￿8nts section of our ￿PorL We are independanl of the trust in requirements that are relevant to our audit of the financial statements in the UK, in Stsndard, and we have fulfilled our other ethical responsibilities in accordanc8 wilh thes thatthe audlt evldéncè we have obtained Is sufflclent and approprfatè to proviclg a basls As (UK)) and applicablè nsibi7ities for the eudit ot rd8nce wilh the elhical ludlng the FRC'S Ethioal requirements. We believe r our oplnloh. conclusio1￿'relatIng to golng conBern In audltbng the finandal statsments. w& h8v8 conch!ded thqt the tru5tBes' use of. th aC￿untIng in the preparation of the financial statements is approprtate: gciog concem basss of Based on the work we have perfornied, we. have not identFffèd any material uncetrdl ccnditions tha( individuaity or collectrvetyi may cast signiff¢2nt doubl .on the IrusY$ abil concem.fora period of al least..twelve months from when the financial Stat￿nents are au ties relating to ev¢nts or to ¢ontinue as a going orfsed for Issue. Our responsibilties and the responsibilities of the trust￿ ￿ respect to'going con relevant sections.of this report, m are deKribed In the Other information The other information comprises the information inddded in thÉ annual rÈpDrt' othpJ th the financial statements and our auditorfs report thereon. The trustees aro. responsibla for th'8 Othw information c tsined wthin the annual reporL Our opinion on the financia]. staternents doe5 not ￿Ver fhe 0th8r inf0m￿tion nd, Èxcept to the extent olh8Mise..expliciUy stated in our report. we do .not expre.sè any forni of assuran conclusion theréon. Our responsibility Is to read the olher infomation and. in doing so. consider whether the oth r infom)ation' is materially inconsistent wlth the finandal statements or our Enowkdge obtained in the course of the diL or othetwiwappears lo be mat8rialty mlsstat9d. If we Identify such material inconslstencles or apparent matè 'al misstatemanls, we are required to delemine whether thls. gives iyse to a material misstatement in the financial atsmeA¢s themselves. tf, based on the work we have performed. we conclude that.there is a material misstatsme l of thi& other information. WB are required to report that fa¢L We have nothing to rèport in this regard.

THE MOUNT VERNON MARIE CURIE RESEARCH WING RUST INDEPENDENT AUDITOR'S REPORT (CONTINUED) TO THE MEMBERS OF THE MOUNT VERNON MARIE CURIE RES TRUST CH WING Opinlons on other matters prescribed by the Companies Act 2006 In our opinion, based on the work undertaken in the course of our autht: th2 infonriation .given in tlie Irustees, report for the financial year for which th prèpared. which include&the'dire¢tO￿. report prepared forthe purposes of crimpan financial statèmenls, and 'tho diractors, report included wlthih the trnst8es' tpport has been prepared In ai requirements. f nanci81 statements are law. ￿ consistent with the ahce wtth appllca'ble.legal matters.on whi¢h.wtr aro ￿luired to report by exception In the light of the knowledge.and understandiTVJ of trust and its environm8nt.obtaine We have not identÉfied material misstatements In the dlrectors, report induded wlthln.the In Ihe course of the aLKr¢ ' report. W8 have nothing to ￿pOrt in respect of We following'rnalters in ￿lation to which tt)e Co us'to report.. to you if.. in our opinion: adequate aGcounting re￿rdS have r#)t been kepi or"retums adequats for our au from branches r]ot vtsiled by u5- or the ftnan¢ial stst8ments.are not ID agreement wllh the ac£OUntin￿ rer>Jrds and retu cèrtain disclosurps of tnjslees, remunérnfjon S￿thed by law are not made; or we have not received all the Information and exptanations we require for our audit.. the trustees were not entilted to prepare the. financial 6tatements in accordance regime and lakp advantsge of the small companies exemptions In preparing the requlrementto prepare a strateglc repo panies Act 2006 requiras it have not baen r8celved or 'th the Bmah companies tees. report and from the Responsibilltles of trustees As explained more fully in th8.Staternent of truste8s' responsibiliti85. Ihe trustees, who a trust for the purpose of company law, are rosponsible for the preparation of the firianGia satisfied that they give a true and fair Mew, and for such intemal control as the trustees enable the preparaton of fjnancial statemerts that ar8 free from materia mlsstatemen error. In p￿ p￿ing the financial statements, the trustees are responsilAe for assessing th as a going concem. disclosing. as applicable. matters.related to going rI)ry￿rn and usifjg accounong unless the trustees either Intend to Itquidat8 the tharitab18 company or to C8 reafisltc allernatÈve.but to do so. also the directors of the tstements and for being etermine. is necessaryto whelher due lo fraud or trust's ab[￿ty to continue e goÈng concem basis of é operaknons, or have no Audibrfs responslbilities for th'e audit of the flnan¢ial Statem￿lts Our objeclives are to obtain reasonable'assurance about whether.the finan(281 ¢atsmen m8t8rlal m15slatemerrt. whethBr due to fraud or erro"r,. and to I£suA 3n .audltt)¢s rèport Reasonable assurance is a high level of assuran￿ but is not a guarantee that an audi with ISAS {UK) always detect a material misstatemeht when it ex-jsts. Misstaternen emr and are consldered material if. ShdI￿dU￿fy or in the aggregate. they could roasonabl the economic decisions.of users taken on the. ba*s of these financial stateriients. as a whole ara.free from t includes our. opinlon. conducted in accordance can arise from fraud or be 8xpecled to influer The extenl to which our procedures are capable of de￿ling irregularftiÈs: indudng fraud isdetaited below. A further descAPOon of our responsibilifias is available on the Financial Reportsnty Co www.fr&org.uklaudftorsresponsibTri ies. This descriptlon forms part of our audilorf.s.fepo ncifs website. atr. htip¥Jl Use of'our report This reportls made solely to fh8 tharlt8ble.compan￿s Membe￿, as a body. in.'acwrdan of the Companies Act2006. Our sudtt work has been undertaken srl that we might State . members those matters we are required to stale to. them in an auditor's report and for fullest.extent pemiitted by law. we do not accept or assume responslbllty to anyone company and the charitablè companys Mernbe￿ as a body. for ourauditwcitK forthis re have fomied. WIUI Chapter 3 of P2rt 16 the.charitablè company's no other purpose.. To the other than the charftable orL or fo'r'the oplnions we

THE MOUNT VERNON MARIE CURIE RESEARCH WING TRUST INDEPENDENT AUDITOR'S REPORT (CONTINUED) TO THE MEMBERS OF THE MOUNT VERNON MARIE CURIE RESEARCH WING TRUST Kleron Pearce FCCA (Senior Statutory Auditor) For and on behalf of Xeinadin Audrt ￿mIted, StatutoryAuditor Chartered Accountants 26 High Street Rickmansworth Hertft)rdshire WD3 1ER 30 June 2025

THE mOUNTv.ERNO￿ MARIE CURIE RESEARCH WING RUST STATEMENT OF FINANCIAL ACTMTIES INCLUDING INCOME AND EXPENDITUREACCOUNT FOR THE YEAR ENDED 30 SEPTEMBER 2024 nr trfcted funds 2024 .Unrestricted funds 2023 Notss Income and endowments ftom: Donations and legacies Charitable actlvtties Inveslmelits Other income 21.604. .g,365 54,485 .5,892 23,023. 23,603 52,478 9..205 Total Income 118,309 Expertdmure on: Raslng funds Charltablè activities 19.451 96,222 113,644 Total expendlture 133,864 115.673 Ngt gainsl(loss•sl on'lnvethtnts 12 126.147 Net income'.and movement.in fvnds 83,629 36,811 Reconcillation of funds= Fund balanGes at 1 October 2023. ,569,021 1,532,211 Fund balances at 30 Sep.tènlber 2024 .652.651 1.569,022 The.statement of firydndal activlties indudes all gains artd losses Tecognised in the year. derive.from confjnulng a¢tivhies. income and expenrfrture Tb&notes on pages 9 to 16 form part of these financial stslements.

THE MOUNTVERNON MARIE CURIE RESEARCH WING RUST BALANCE SHEET AS AT30 SEPTEMBER 2024 2024 2023 Fixed assets Invastrnents 14 1.,444,088 1293,509 Current assets Debtors Cash at bank and in hand 15 45h25 21.4.034 34,023 28g.792 259,459 Creditors: amounts falling due wtthln one:'year 323,815 (50.896) (48,302.) Net current assets 208,563 275.513 Total assets le￿ current Ilabilitios 1,652,651 1,569,022 The funds of th? trust Unrestrlcted fund.s 17. 1.652,651 1,569,022 1,652.651 1,$69,022 The notes on pag¥'9 to 16 fonyb pert of'these Ilnancial slatements. The ftnancial statèments Wère approved by the.tnths o 7AZ¢ Dr R Alonzl Trustee rof P Hoskln Trustee DrAMakris Dr K Chiu Trustee Trustee Company registra￿On number 04110627 (England and Wales)

THE MOUNT VERNON MARIE CURIE RESEARCH WING RUST NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2024 Accounang p0￿Cl￿ Charity inforniation The Mount VÈmon Marie Curie Research w￿g. Trust is a privat"e'company IRmited in England arjd Wabs. Thé registered office is The Mount VemoY Marie Curie Mount Vemon Hos*l. R1dm￿nsWOrth Road, Northwood: Middlese& HA6 2RN, E y guarantee incDrp.orated esearch Wiro.. 1st Floor, land, 1.1 Accounting convention The financial staternents have been prepared in acoNdance V￿th the trust's Companies Act 2006. FRS 102 Yh6 Finawaj RepoTting Standard applicable i Ireland. and the Charities SORP 'AcLounting and Reporting by Charities: Sts Prathce applicab]e' to chariknes preparing Iheir accounts in accordance with the Fi appliGable in the UK and Republic of I￿13nd (FRS. 102)". The.frust Is a Public Bene oveming douJmenL 'th"e th8 UK and Republic of ment of Recommended ncial Rep(wting standard Entity as defined by FRS The twst has. taken.advantage of the prDvlslons in the SORP for charjiles not te p pare a stslemèht of G8sh The ffnanclal statements a￿ prepared in sterlng: ithich b the fvD¢tional curr Blnounts in thesa financial ststsments are rounded to the nearest £ of the trust. Monetary Th& finandal statements have been prepared under the historical cost conventlon poli¢les adopted are set outbalow. The principal accountÉng 1.2 Golng concem At the time. of approving the financial ststements, the tnjstees have 8 reasonable has.'adequate resources to continue in oPerat￿nal existence ft)r the foreseeable Gonlinue to adopt the goins concèrn basls of accourrtirwJ n prepariry Ihe ffnancial s 8xpeclation that he trust fvbjre. Thus the fnJstee$ teménts. 1.3 Gharitable funds UnrestrSGted fijnds are. avali able 'for use at. Ihe dlscretion of the Injstees in fu objectives. rance of their charitable 1.4 In¢oThO Income is recognksed when tho trust is legally 8nttt]ed to it after ary perfo￿￿2￿Ce the amounts tran be m￿SUTed Teliably. and it is probabb that inrnmp WHI be receiv onditlons have been rnet, Cash donalions are recognised on receipL Otr¢er donalions arè recogrused onc8 th the donation,"untess performance con￿￿ons.reqU1r& defÈrTal of the amounL Income to donations re￿iVed under GiftAid or deeds cf covenant Is recognised at the t￿ne trust has been notifièd of recoverable Ih"relation f thE donatson. Legacaés a￿ recognised on receipt or olh8Trvtse if the tnist has been notified of an amount is kno￿. and receipt Is expected. If tlie amount is not luThn, the legacy asset. pon(fing distribu￿On, the 5 treated as a contlngent

T.HE MOUNTVERNON MARIE CURIE RESEARCH WING RUST KOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 30 SEPTEMBER 2024 Accounting pollcies '(Continued) 1.5 Expenditure Exp8nditure is r8cognised once there is a legal or construthve obligation lo tran third paty, it Is probable that a transfer of economtc benefits. will be r8quired in s 1he obligatlon can be measured reliabty. Expenditure is classtfied by acbvity. The cost& of eath actsvity fi￿ made up of shared costs. i1)c￿dIng support costs involved in undertaking each activlty. Dlre-t c activity are auocatsd dÉrect]y to that actiwty. Shared costs which coRtibute to support Costs ithich are not attributable to 2 single activity are apportioned be￿e nsistant with the use of 'resour¢XS. Central staff Costs are allocated cn the depredatlcin tharges are allocated on portlon of the assefs use. rer 8conomiG benefit to a emenk and the amount of total of direct costs and attrlbulable. b.a single" re than one activSty 4nd those activitleg on.a basis asis of time spent, 'and 1.6 Flxed asset investments Fixed asset rnvestments are initiaily measured at transartion price exdudlng subsequently measured at fair value al each reporting. date. Changes in fair v Incomollexpanditure) far the year. TransaGtion costs are eXper￿d as incurred. nsaction oxts, and ar8 ue aTe rec4)gntsed in n'et 1.7 Cash and cash equivalents Cash and .cash equiva]ents Include cash in ThaDd'. deposits held at call with ban intrestments with original matufities of thrBo months or less. and bank overdr.afts. within borrowtngs in current liabilitie& other short-lerm liquid ?nk overdrafts arè shown. 1.8 Financial instruments Thè trust has'elected to apply the provisions of Sedion 11 'Baslc Financial Instnjm .Financial Instrum8nts Issues. of FRS 102 to all of Its financ￿￿ instruments. nts and Sectlon 12 '0thèr Inancial instwments are recognised. in the trusts balance sheet then the t ntractiial provisions of the InstrumenL st becomes paty to thè Flnancial assets and liabllStES are otset, with the net amounts presented In the there is a legally enforceable right to sel off the recognised 7mounts arKI Ihere is an baas or to reallse the asset and settle the liabifty simult4neou81y. ancxal statements, when ntentic?n to settle.on a net Basic financlal assets BasiG financial asèets, whith inclvd& debtors end "¢ash and bank baknc8s. transaction Pri￿ including transaclion costs and are 5ubsequentty Ixrried at arno Interest method unless thè .arrangément ¢onstitute5 a finandng transactton. measured.at. ihe present value of.the fijlU￿ receipts discounted at a market rate o classified.as receivable withln one year are riot amartised. re inTiially measured at d cost using the effectwg Ère thè transaction 15 interest. Ftnancial assets Basic'r Inancial Ilabllities Basic financial liabilities. includlng creditors and bank loans are Initially r9¢x)gnised the arrangÉment constilutes. a financing transactson. where the debt inslNment i t transaction price unless measured at tTrJè present value of the future payrnerits dlscounted at a market rate of IrrteresL FIr￿n¢la1 liab"'ties ciassifipd as'pay'able within one.year are not amortised. Debt iiistruments are subsequenty 1*rri￿at amortised (xjrt Jjsing the effeclive in Trade creditors are obligalK>ns ta pay for'goods or servKes Ihat have been acqui operations fro.m stsppliÉrs. Amounts payable are classified as currenl" liabiliiie5 rf year or less. If not.. they are presented as nonairrent liabiffies. Trade ueditors transaction prlce and subsequentty" measured at amortised O￿t using the.effective est rats meihcd. in Ihe" ordinary.cours&.'of yThent due within onè retsgnised initially at tereg..method.

THE MOUNT VERNON MARIE CURIE RESEARCH WING RUST NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 30 SEPTEMBER 2024 A¢£ounting poficies (Continued) Derecognillon of financlal liabilities Financial fiabtrrtÉ8s .are derecognised when ihe 'trusYs contrdclual obltgations cancelled. irg or. are .distharged or 1.9 Employee'benefits The cost of any unused holiday eNffttem8nt is recognised in the perfod in which.th ernptOy8e's seNicès are TermÈnation benefits'are recognised immediately as aD expense when the trust is termlnafe.the emptoyment of7n employee ar to pp)vid8 termination beneftt& monstrably Gomrritted to Income from donations and legacles Unr 5trfcted funds 2024 Unrestrlcted funds 2023 Donations and grfts Legaaes 21,104. 500 28,023 5.000 21,6Q4 33,023 InGome from ¢harltable actlvllles strieted 'funds 202 Unrestricted funds 2023 Research"into and education on oncology. P¢rforth'an¢e relat￿ grants. 9.366 23.603 In￿me from Investments estricted Urtrestrlcted funds fund$. 2024 2023 Income frorn listed invesbnents Interest recei¥rable 51.652 1833 51,.186 1.,292 54.485 52,478 11

THE.MOUNT VERNON MARIE CURIE RESEARCH WING RUST NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 30 SEPTEMBER 2024 Other income restricted Unrèstrfcted fvnds funds 2024 2023 Tralnlng irbcome Other income 1..93& 3,954 2.407 5.892 EXpendI￿re on ralslng funds. rostricted UnrestriGte.¢ fvnds funds 2024 2023 Inveslm8nt management 20220. Expendituro on chaTStable aetlvilies Research Research into and into and ducatlon èducalio oncology on oncology. 2024 .2023 on Dlrect costs Staff costs Research mateAals Lecture fees Conf•renc8s Computer & office.¢osts Medlcat equipment 32,306 984. .2,669 26,dS4 7,51.7 5,052 155 47.405 385 500 84.384 73.682 .Share' of support and governattce eosts (see no'te 8) support 29.280 22.54Q 113.644 96.222 Analysis by.fund Unrestricted fijnds 113.844 96,222 Durfng tha year ar) ex-gratia.'payment of has been ac&ryJed to the voluntBer. '.as thanks for the work undertaken in managing the tharitie5 accounting functt¢in. ooJd(eeper for the charity --1.2-

THE MOUNT VERNON MARIE CURIE RESEARCH WING RUST NOTES TO THE FINANCIAL STATEMENTS (CONTNU.ED) FOR THE YEAR ENDED 30 SEPTEMBER 2024 sup.port eosts allocaled to acbvities arch Into ucatlon oncology 2024 Total and pn 2023 Subscriptions Administrative expenses. Travelling Student tralning Governance 1.281 6,962 1.9D3 12,069 7.746 29,260 22.540 Net movement in funds 2024 2023 The net movement iri.funds Is stated after chargingl(crediting): Fees payable for the audit of the charl￿5 financial slatements 5,100 4.5È0 10 Trust••s None of lh8 .trustees .(or any persons conn8Cted Y￿th them) received aFry' remune tru'st during the year. During the year4 Trustees Were reimbursed expenses lotalllng £4,735 (2023. £3,12 tlon or bgnafits from the .11 Ernployoos The average monlhty'nutnber of emp.toye8s during the yearwas: 2024 Number 2023 Number Res.éarch staff Etnployment Gr)sts 2024. 2028. w8ges.and salaries 33,481 There wer6 no èmployees wlloge annuaI.remurEration was moro than £60.01)O. 13-

THE MOUNTVERNON MARIE CURIE RESEARCH WING RUST N.OTES TO THE FINANCIAL STATEMENTS {CONTINUED) FOR THE YEAR ENDED 30 SEPTEMBER 2024 12 Goins.and losses on imvestm8nts restricted Unreslrlcted funds funds .2024 2023 Gainsl(losses) arising on- 'R£valuaUon of investrnÈnts 126.147 34.175 13. Taxation The dlarity Is exempt from taxation on its activibea beixuse all its income Is applied forcharitsb18 purposes. 14 Fixed asset investments Listed investments Cost orvaluatioh .At 1. October 2023 Addffjons. Valtratlon"Ghanges Disposals 1.293,50'9 324,034 t32,250 (305,705.1 At 30 September 2024 1,444,088 Carrying amount At 30 September 2024 1.444,088 At 30 Septernber 2023 1.293,509 q.5. Debtors 2024. 2023 Amounts fallng due. within one yaar: other'dèbtors Prepayments and ewrued In￿￿8 19,859 25,566 1'7,394 16.629 45,425 34.023 .6 Crndstors-. tmtsunts taifing due wtthin on8 year 2024 2023 Trade crethtOTS A¢cruals and defeThed incorrte 10,800 40,096 .32,T29 14.573 50.896. 48,302 -14-

THE MOUNTVERNON MARIE CURIE RESEARCH WING RUST NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 30 SEP.TEMBER 2024 17 Unrestricted lunds The unrestricted funds of the cham.ty Comprise lh8 unexp8nded ba'lances of donatio nDt subject to sperAfic c*nrfrtion& by donors arid grantors as to how they may be us d8signated funds which have been set£side out of unreslricted fvnds by the truste and grants whlth are . These include for specific purposes. At 1 October 2023 Incoming sources Resources expended ains and losses .At 30 September 2024 Dr'P Hoskin Dr K Chlu Dr D Mile5 DrA Makr&s Breast Development F￿hting breast cancer Staff development Cybert(nife Brad)y General fvnds Dr P Ostler Dr M Harrison Dr N Shah Dr S Mawdlsey Dr R Alonzr Dr Guppyjwesbtury Dr N Bhuva DrA Vinayan 59&,717 184.7TO 103.218 34.018 .10,924 3.398 3,131 (55,896) (4,720) (10,418) (21.591) (1,380) (1252) {574) (6.117) (215) (34) (14,111) (8565 (6,490) {6,516) (199) (3.oon (409) (87} (12) 47,975 14,855 8,300 7.646 4.014 622.814 205.829 104,498 84.291 54,206 106,909 52,439 79,641 18.362 5,168 116,g42 29.857 15,701 74.861 6,991 49.928 97.153 42.998 .029 16.686 2.652 115,916 27.587 19.932 73.094 1S.4?11 37..584 7,084 3,198 6,558 2,536 549 2.337 5,818 908 656 1406 508 8,812 83 2,672 1,040 3,457 6,193 1,342 213 9,'319 1241 3.022 570 419 73 7,478 8,247 2,006 1.569,022 91.346 (133.8845 126,147 1.652,6$1 -15.-

THE MOUNTVERNON MARIE CURIE RESEARCH WING UST NOTES TO THE FINANCIAL STATEMENTS (CONTINUED.). FOR THE YEAR ENDED 30 SEPTEMBER 2024 17 Unrestrlcted funds [ConthiLtÈd Prevlous year. At 1 Odober 2022 Incoming resour¢2s Resources expended ins and 105ses At30 Seplember 2023 Dr P Hoskin Dr K Chlu Dr D Miles DrA Mark .Breast Pevelopment Fighling. breast trancer Staff devehjpmènt Cybetknlfe 582.790. 184.809 102,602 97.511 48.842 93,14S 38,371 73,853 14.244 2.542. 119,580 27,394 19,110 70.721 14,804 .25.341 8.598 9,582 49,2T4 11,371 .3,428. 3.258 (48.34n (15,532) (5.100) 17.839) (1,635) (1,182) (5,859) {938) (1.4e3) (32) [16.609) (1,333) {243) 13,000 598,717 184.7TO 103,218 95,105 49,928 97,153 42,998 77,029 16,686 2,652 115,916 27,587 19,932 73,.094 1S,441 37,584 7.084 5223 905 2,288 2.175 .3.112 9,630 2,467 3,587 85 10,278 915 639 1363 495 13.855 2,078 856. 1,647 318 57 2.667 General funds Dr P Osti8r Dr M H*rison Dr N Shah Dr S Mawdlsey Dr RAlonzi Pr Guppyfflesblury DrN Bhuva DrA Ifinayan 426 .1,577 330 S65 f47 214 (188) (2.177) (604) (4,893) 320 657 1,532 211 118.309 (115,&73) 34,175 1,5fj9,022 When funds are re¢eNed' for 8 .$pecific corKsulianL they arB allocated to the rele other receipts are allocatedlo the g8n8ral )TrJnd. t consultarits fund. Aiiy The geneRI, breas( fighting breast cancer and devekjpment fvnds are not aifocate and are for.'general use on cancer ￿rCh. to one specific consultant The staff development fund is a designaled for staff and student dovelopmènL Cy are designated'for research ih Improving those specific treatments. knlfe and 'Brachy funds 18 Related party transactlons There weté dlsclosable related paty transactÉons during the yèar (2023- none). There were nc¥.related paty transactlons forthe year ended 30.September 2024. 19 Ultlmate Gontrolling party The trustees be￿eve there is no ullimate contrDifing party. 16-